SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $282 | -99.9% | 7,405 | -17.4% | 0.01% | -14.3% |
Q3 2022 | $351,000 | -3.8% | 8,961 | -20.8% | 0.01% | +27.3% |
Q2 2022 | $365,000 | -2.4% | 11,309 | +0.2% | 0.01% | +22.2% |
Q1 2022 | $374,000 | -32.1% | 11,291 | -12.9% | 0.01% | -18.2% |
Q4 2021 | $551,000 | +21.4% | 12,963 | +26.5% | 0.01% | +10.0% |
Q3 2021 | $454,000 | -25.2% | 10,251 | -4.1% | 0.01% | -16.7% |
Q2 2021 | $607,000 | -19.8% | 10,691 | +5.7% | 0.01% | -20.0% |
Q1 2021 | $757,000 | +99.2% | 10,111 | +130.4% | 0.02% | +87.5% |
Q4 2020 | $380,000 | +41.8% | 4,388 | 0.0% | 0.01% | +33.3% |
Q3 2020 | $268,000 | +47.3% | 4,388 | 0.0% | 0.01% | +20.0% |
Q2 2020 | $182,000 | +42.2% | 4,388 | -1.9% | 0.01% | +25.0% |
Q1 2020 | $128,000 | -61.0% | 4,473 | -1.5% | 0.00% | -42.9% |
Q4 2019 | $328,000 | -50.0% | 4,543 | -2.8% | 0.01% | -53.3% |
Q3 2019 | $656,000 | -24.0% | 4,675 | -0.8% | 0.02% | -21.1% |
Q2 2019 | $863,000 | +12.5% | 4,715 | -2.3% | 0.02% | +11.8% |
Q1 2019 | $767,000 | +230.6% | 4,824 | +99.3% | 0.02% | +183.3% |
Q4 2018 | $232,000 | -37.3% | 2,420 | -7.6% | 0.01% | -14.3% |
Q3 2018 | $370,000 | -9.8% | 2,620 | 0.0% | 0.01% | -12.5% |
Q2 2018 | $410,000 | -6.4% | 2,620 | -3.7% | 0.01% | -11.1% |
Q1 2018 | $438,000 | – | 2,720 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |